You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大成生化科技(00809.HK)中期亏损扩大11.2%至8亿港元
格隆汇 08-27 21:58

格隆汇8月27日丨大成生化科技(00809.HK)发布中期业绩,截至2019年6月30日止6个月,公司实现收益27.994亿港元,同比减少4.6%;毛利5376.1万港元,同比减少68.0%;公司拥有人应占亏损8.006亿港元,同比扩大11.2%;基本每股亏损12.5港仙;不派中期股息。

报告期内,集团综合收益轻微减少约4.6%,主要是由于集团下游赖氨酸及甜味剂产品的销量下降所致。就原材料成本而言,由于省政府的农业补贴政策有所改变,集团于期内并无从中获得玉米采购补贴(2018年:4180万港元)。

另一方面,尽管饲料行业对玉米的需求且非洲猪瘟的关系而有所萎缩,但由于玉米颗粒供应随着中国的旧玉米存货逐渐消化而减少,加上生物燃料行业需求殷切,玉米价格在期内仍趋稳定。集团于期内的玉米颗粒采购价格增加2.3%。同时,受非洲猪瘟影响,集团上游其他玉米提炼产品及氨基酸产品的平均售价分别于期内减少26.1%及10.5%。因此,集团的毛利及毛利率分别减少68.0%及3.8个百分点至约5380万港元及1.9%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account